Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu; María D. Belles-Medall; Raúl Ferrando-Piqueres; Pedro Almela-Notari; María Mendoza-Aguilera; Tamara Álvarez-Martín;

Evaluation of persistence, retention ¿rate¿ and prescription pattern of original infliximab and infliximab CT-P13 in biologic-naïve patients with ulcerative colitis Alejandro Valcuende-Rosique; Joaquín Borrás-Blasco; Sandra Martínez-Badal; Xavier Cortes; Celia Aparicio-Rubio; Elvira Casterá-Melchor;

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs José Manuel Martínez-Sesmero; Javier De Castro-Carpeño; Araceli López-de las Heras; Alonso Fernández-Nistal; Francisco Javier Parrondo-García;